Mersana Therapeutics (MRSN)
(Delayed Data from NSDQ)
$2.85 USD
-0.03 (-1.04%)
Updated Apr 25, 2024 04:00 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.18 |
EPS Last Quarter | -0.16 |
Last EPS Surprise | 20.00% |
ABR | 1.44 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.60 |
Next Year | -0.67 |
EPS (TTM) | -1.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 9.75M | 10.15M | 51.03M | 39.77M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 10.00M | 10.30M | 70.00M | 43.10M |
Low Estimate | 9.50M | 10.00M | 40.00M | 35.00M |
Year ago Sales | 7.80M | 10.65M | 36.85M | 51.03M |
Year over Year Growth Est. | 25.00% | -4.69% | 38.47% | -22.08% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.18 | -0.17 | -0.60 | -0.67 |
# of Estimates | 4 | 3 | 5 | 5 |
Most Recent Consensus | -0.21 | -0.22 | -0.87 | -0.74 |
High Estimate | -0.13 | -0.13 | -0.25 | -0.33 |
Low Estimate | -0.21 | -0.22 | -0.87 | -0.86 |
Year ago EPS | -0.52 | -0.47 | -1.48 | -0.60 |
Year over Year Growth Est. | 65.38% | 63.83% | 59.46% | -12.67% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 0 | 3 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 2 | 2 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.18 | -0.17 | -0.60 | -0.67 |
7 Days Ago | -0.18 | -0.17 | -0.60 | -0.67 |
30 Days Ago | -0.18 | -0.17 | -0.60 | -0.67 |
60 Days Ago | -0.20 | -0.18 | -0.65 | -0.62 |
90 Days Ago | -0.20 | -0.18 | -0.65 | -0.62 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.18 | -0.17 | -0.60 | -0.67 |
Zacks Consensus Estimate | -0.18 | -0.17 | -0.60 | -0.67 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.16 | -0.35 | -0.47 | -0.52 | NA |
Estimate | -0.20 | -0.31 | -0.39 | -0.41 | NA |
Difference | 0.04 | -0.04 | -0.08 | -0.11 | -0.05 |
Surprise | 20.00% | -12.90% | -20.51% | -26.83% | -10.06% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more